No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs116551781 |
chr14:38368505-38368506 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs79211361 |
chr14:38368601-38368602 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs529451001 |
chr14:38368673-38368674 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs186084923 |
chr14:38368686-38368687 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs116345984 |
chr14:38368713-38368714 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs577830467 |
chr14:38368720-38368721 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs571025498 |
chr14:38368731-38368732 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs539455881 |
chr14:38368735-38368736 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs553306620 |
chr14:38368752-38368753 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs573271984 |
chr14:38368800-38368801 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs541955176 |
chr14:38368905-38368906 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs561825612 |
chr14:38368937-38368938 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs188385608 |
chr14:38368951-38368952 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs544390730 |
chr14:38368966-38368967 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs181246935 |
chr14:38369022-38369023 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs533627881 |
chr14:38369048-38369049 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs185750859 |
chr14:38369061-38369062 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs560057816 |
chr14:38369156-38369157 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs528865350 |
chr14:38369220-38369221 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs528801532 |
chr14:38369250-38369251 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs568969112 |
chr14:38369283-38369284 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs145469274 |
chr14:38369302-38369303 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs147681060 |
chr14:38369404-38369405 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs571476635 |
chr14:38369415-38369416 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs534060671 |
chr14:38369432-38369433 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs541539727 |
chr14:38369476-38369477 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs190406015 |
chr14:38369589-38369590 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs546740213 |
chr14:38369633-38369634 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs117132233 |
chr14:38369649-38369650 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs149140776 |
chr14:38369802-38369803 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs555479605 |
chr14:38369803-38369804 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs8005895 |
chr14:38369816-38369817 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs544404872 |
chr14:38369819-38369820 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs183804954 |
chr14:38369825-38369826 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs375339902 |
chr14:38369844-38369845 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs551313898 |
chr14:38369857-38369858 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs560599160 |
chr14:38369962-38369963 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs187155043 |
chr14:38370009-38370010 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs528941261 |
chr14:38370064-38370065 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs566644173 |
chr14:38370078-38370079 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs58800582 |
chr14:38370084-38370085 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs542606224 |
chr14:38370174-38370175 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs562575368 |
chr14:38370182-38370183 |
Weak transcription Flanking Active TSS Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs531408930 |
chr14:38370303-38370304 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs543086001 |
chr14:38370322-38370323 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs369900188 |
chr14:38370323-38370324 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs571453953 |
chr14:38370397-38370398 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs569361105 |
chr14:38370416-38370417 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs12590816 |
chr14:38370422-38370423 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs558147455 |
chr14:38370423-38370424 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|